These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 27404679)

  • 1. Amelioration of right ventricular function after hybrid therapy with riociguat and balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension.
    Tsugu T; Murata M; Kawakami T; Kataoka M; Nagatomo Y; Tsuruta H; Itabashi Y; Maekawa Y; Fukuda K
    Int J Cardiol; 2016 Oct; 221():227-9. PubMed ID: 27404679
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinically Worsening Chronic Thromboembolic Pulmonary Hypertension by Riociguat After Balloon Pulmonary Angioplasty.
    Minatsuki S; Hatano M; Kiyosue A; Saito A; Maki H; Takimoto E; Komuro I
    Int Heart J; 2018 Sep; 59(5):1186-1188. PubMed ID: 30158388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic thromboembolic pulmonary hypertension: the evolving treatment landscape.
    Kim NH; Mayer E
    Eur Respir Rev; 2015 Jun; 24(136):173-7. PubMed ID: 26028629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Change of right heart size and function by long-term therapy with riociguat in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
    Marra AM; Egenlauf B; Ehlken N; Fischer C; Eichstaedt C; Nagel C; Bossone E; Cittadini A; Halank M; Gall H; Olsson KM; Lange TJ; Grünig E
    Int J Cardiol; 2015 Sep; 195():19-26. PubMed ID: 26011408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemodynamic effects of riociguat in inoperable/recurrent chronic thromboembolic pulmonary hypertension.
    Kim NH; D'Armini AM; Grimminger F; Grünig E; Hoeper MM; Jansa P; Mayer E; Neurohr C; Simonneau G; Torbicki A; Wang C; Fritsch A; Davie N; Ghofrani HA
    Heart; 2017 Apr; 103(8):599-606. PubMed ID: 28011757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Balloon pulmonary angioplasty combined with riociguat for the treatment of inoperable chronic thromboembolic pulmonary hypertension (PRACTICE study): study protocol for a randomized controlled trial.
    Zhao QH; Gong SG; He J; Yuan P; Wu WH; Luo CJ; Jiang R; Zhang R; Qiu HL; Li HT; Li Y; Liu JM; Wang L
    Trials; 2021 Dec; 22(1):957. PubMed ID: 34961562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Chronic Thromboembolic Pulmonary Hypertension: The Role of Medical Therapy and Balloon Pulmonary Angioplasty.
    Fernandes TM; Poch DS; Auger WR
    Methodist Debakey Cardiovasc J; 2016; 12(4):205-212. PubMed ID: 28289495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Riociguat: stimulator of soluble guanylate-cyclase. New mode of action for the treatment of pulmonary arterial and non operable chronic thromboembolic pulmonary hypertension].
    Leuchte HH; Behr J; Ewert R; Ghofrani HA; Grünig E; Halank M; Held M; Klose H; Rosenkranz S; Schermuly RT; Wilkens H; Hoeper MM
    Pneumologie; 2015 Mar; 69(3):135-43. PubMed ID: 25750094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Balloon pulmonary angioplasty vs riociguat in patients with inoperable chronic thromboembolic pulmonary hypertension: A systematic review and meta-analysis.
    Wang W; Wen L; Song Z; Shi W; Wang K; Huang W
    Clin Cardiol; 2019 Aug; 42(8):741-752. PubMed ID: 31188483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Right ventricular size and function under riociguat in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension (the RIVER study).
    Marra AM; Halank M; Benjamin N; Bossone E; Cittadini A; Eichstaedt CA; Egenlauf B; Harutyunova S; Fischer C; Gall H; Ghofrani HA; Hoeper MM; Lange TJ; Olsson KM; Klose H; Grünig E
    Respir Res; 2018 Dec; 19(1):258. PubMed ID: 30567595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of responder threshold criteria to evaluate the response to treatment in the phase III CHEST-1 study.
    D'Armini AM; Ghofrani HA; Kim NH; Mayer E; Morsolini M; Pulido-Zamudio T; Simonneau G; Wilkins MR; Curram J; Davie N; Hoeper MM
    J Heart Lung Transplant; 2015 Mar; 34(3):348-55. PubMed ID: 25813765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Riociguat treatment in patients with chronic thromboembolic pulmonary hypertension: Final safety data from the EXPERT registry.
    Ghofrani HA; Gomez Sanchez MA; Humbert M; Pittrow D; Simonneau G; Gall H; Grünig E; Klose H; Halank M; Langleben D; Snijder RJ; Escribano Subias P; Mielniczuk LM; Lange TJ; Vachiéry JL; Wirtz H; Helmersen DS; Tsangaris I; Barberá JA; Pepke-Zaba J; Boonstra A; Rosenkranz S; Ulrich S; Steringer-Mascherbauer R; Delcroix M; Jansa P; Šimková I; Giannakoulas G; Klotsche J; Williams E; Meier C; Hoeper MM;
    Respir Med; 2021 Mar; 178():106220. PubMed ID: 33540340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic thromboembolic pulmonary hypertension: interventional approaches.
    Hoole SP; Jenkins DP
    Heart; 2020 Oct; 106(19):1525-1531. PubMed ID: 32404404
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of riociguat on right ventricular function in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
    Benza RL; Ghofrani HA; Grünig E; Hoeper MM; Jansa P; Jing ZC; Kim NH; Langleben D; Simonneau G; Wang C; Busse D; Meier C; Ghio S
    J Heart Lung Transplant; 2021 Oct; 40(10):1172-1180. PubMed ID: 34353714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent progress in the diagnosis and management of chronic thromboembolic pulmonary hypertension.
    Tanabe N; Sugiura T; Tatsumi K
    Respir Investig; 2013 Sep; 51(3):134-46. PubMed ID: 23978639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Riociguat for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: Results from a phase II long-term extension study.
    Halank M; Hoeper MM; Ghofrani HA; Meyer FJ; Stähler G; Behr J; Ewert R; Fletcher M; Colorado P; Nikkho S; Grimminger F
    Respir Med; 2017 Jul; 128():50-56. PubMed ID: 28610669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Refined balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension.
    Mizoguchi H; Ogawa A; Munemasa M; Mikouchi H; Ito H; Matsubara H
    Circ Cardiovasc Interv; 2012 Dec; 5(6):748-55. PubMed ID: 23192917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spontaneous enlargement of pulmonary artery after successful balloon pulmonary angioplasty in a patient with chronic thromboembolic pulmonary hypertension.
    Nagayoshi S; Ogawa A; Matsubara H
    EuroIntervention; 2016 Dec; 12(11):e1435. PubMed ID: 27934612
    [No Abstract]   [Full Text] [Related]  

  • 19. Retrograde Approach in Balloon Pulmonary Angioplasty: Useful Novel Strategy for Chronic Total Occlusion Lesions in Pulmonary Arteries.
    Kawakami T; Kataoka M; Arai T; Yanagisawa R; Maekawa Y; Fukuda K
    JACC Cardiovasc Interv; 2016 Jan; 9(2):e19-20. PubMed ID: 26723765
    [No Abstract]   [Full Text] [Related]  

  • 20. Riociguat for the treatment of chronic thromboembolic pulmonary hypertension.
    Ghofrani HA; D'Armini AM; Grimminger F; Hoeper MM; Jansa P; Kim NH; Mayer E; Simonneau G; Wilkins MR; Fritsch A; Neuser D; Weimann G; Wang C;
    N Engl J Med; 2013 Jul; 369(4):319-29. PubMed ID: 23883377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.